Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Med-El Corporation
Participants will be randomized into a starting frequency setting at device activation or shortly after device activation for the first three months of device use. After 3 months listening experience, participants will be randomized into different frequency settings and tested before and after a period of listening experience. Participant outcomes for each of the multiple frequency settings will be evaluated using standard clinical speech testing and through questionnaires designed to capture information about patient sound quality and quality of life.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least 18 years of age
Is a cochlear implant candidate as deemed by the participating center
Implanted (or to be implanted) unilaterally with a MED-EL cochlear implant with moderately severe or better acoustic hearing in the contralateral ear.
For patients who are already implanted, device activation must have occurred within 2 weeks of enrollment
Patients with moderate contralateral hearing loss or greater must utilize a hearing aid in the contralateral ear.
Programmed with electric-only stimulation in the implanted ear
The ear to be implanted, acoustic hearing thresholds must be no better than 50 dBHL at 250 Hz and 65 dBHL at 500 Hz
Post-operative CT scan allows for completion of OTOPLAN analysis
ABF settings possible at defaults in clinical programming software
Minimum of 10 active electrodes at activation
Programmed using a Fine Structure coding strategy
English is the primary language
Willing and able to comply with all scheduled procedures as defined in the protocol
Subjects who receive a cochlear implant in the contralateral ear prior to the 12-month interval
Clareo Health | Impact of Anatomy-Based Cochlear Implant Programming on Early Performance
